Directed human immune globulin for the prevention and treatment

Details Directed human immune globulin for the prevention and treatment Directed human immune globulin for the prevention and treatment

1995-06-02

1999-09-21

Spiegel, Carol A.

Drug, bio-affecting and body treating compositions

Immunoglobulin, antiserum, antibody, or antibody fragment,...

424 858, 435 733, 4352528, A61K 39395

Patent

active

059550740

ABSTRACT:
This invention is directed to a Directed Human Immoglobulin and compositions thereof for preventing or treating staphylococcal infections such as S. epidermidis in neonates.

REFERENCES:
patent: 4027010 (1977-05-01), Kiselev et al.
patent: 4197290 (1980-04-01), Yoshida
patent: 4482483 (1984-11-01), Curry et al.
patent: 5530102 (1996-06-01), Gristina et al.
Wedren, H., Scand. J. Urol. Nephrol. Suppl., 1989, vol. 123, p1-36.
Fischer, GW. Pediatric Clinic of North America, vol. 35(3), Jun. 1988, p5533.
Kamdar, SS et al, Indian J. Med. Res., Oct. 1990, vol. 92, p337-40.
Yang, KD et al, J. of Infect. Dis. vol. 159(4) Apr. 1989, p701-707.
Gunn, BA., J. of Clinical Microbiol., Mar. 1989, vol. 27(3), p507-511.
Verhoff, J. et al, Scan. J. Infect. Dis, Suppl. vol. 41, p56-63, 1983.
Clark, LA et al, J. Clin. Path., 1986, vol. 39, p856-860.
Conway, SP et al, Vox Sang, 1990, vol. 59(1), p6-11.
Etzoni, A et al, Acta Paediatr Scand, vol. 79, p156-161, 1990.
Gonzalez, LA et al, Pediatr. Infect. Dis. J., 1989, vol. 8(5), p315-322.
van Bronswijk et al, Immunology, 1989, vol. 67, p81-86.
Bussel, JB et al, May-Jun. 1990, 12 Suppl. 4, p5457-461, Rev. Infect. Dis.
Counter, F.T. et al, J. of Antibiotics, Jun. 1990, p616-618, vol. XLIII (6).
Clapp, D.W et al, Dec. 8, 1989, J. Pediatrics, vol. 115, p973-978.
Verhoff, J et al, Immunol. 1977, p191-197, vol. 33.
Baker, Carol J., Pediatric Res., vol. 25(4), part 2, Apr. 1989, p. 275A, abstract #1633.
Arakawa, S. et al, Nishinihon Journal of Urology, vol. 49(4), 1987, p1007-1014, English abstract, and table on p. 1010.
Weisman, E. et al, The Am. Ped. Soc. and Soc. Ped. Res., May 7-10, 1990, Abst. 1648, p. 277A.
Hague, K.N. et al, Am. J. Dis. Children, Dec. 1988, vol. 142, p1293-1296.
Carozzi, S. et al, Trans. Am. Soc. Artif. Intern. Organ, vol. XXXIV, 1988, Jul.-Sep., vol. 34(3), p635-639.
Lamperi, S. et al, Biomat. Artif. Cells Artif. Organs, 1987, vol. 15(1), p151-159.
Timmerman et al., Characterisation and Functional Aspects of Monoclonal Antibodies Specific for Surface Proteins of Coagulase-Negative Staphylococci, J. Med. Microbiol., vol. 35, pp. 65-71 (1991).
Niizuma, T, Chem. Abs., vol. 115, p713, #181022v, 1990.
Biotechnology Newswatch, A. McGraw-Hill Production, pp. 2-3, Oct. 4, 1993.
Ichiman et al., Induction of Resistance with Heat-Killed Unencapsulated Strains of Staphylococcus epidermidis Against Challenge with Encapsulated Strains of Staphylococcus epidermidis, Microbiol. Immunol., vol. 33 (4), pp. 277-286, (1989).
Ichiman et al., "Protective Antibodies in Human Sera Against Encapsulated Strains of Staphylococcus epidermidis," J. Appl. Bacteriol., 63:165-169 (1987).
Clark et. al., "Opsonic Activity of Intravenous Immunoglobulin Preparations Against Staphylococcus epidermidis," J. Clin. Pathol., 39:856-860 (1986).
Clark et al., "Opsonic Requirements of Staphylococcus epidermidis," J. Med. Microbiol., 22:1-7 (1986).
Fleer et al., "Opsonic Defense to Staphylococcus epidermidis in the Premature Neonate," J. Infect. Dis., 152:930-937 (1985).
Fleer et al., "Septicemia due to Coagulase-negative Staphylococci in a Neonatal Intensive Care Unit: Clinical and Bacteriological Features and Contaminated Parenteral Fluids as a Source of Sepsis," Pediatr. Infect. Dis., 2:426-431 (1983).
Fischer et al., "Diminished Bacterial Defenses with Intralipid," The Lancet, 2:819-820 (1980).
Yoshida et al., "Immunological Response to a Strain of Staphylococcus epidermidis in the Rabbit: Production of Protective Antibody," J. Med. Microbiol., 11:371-377 (1977).
Yoshida et al., "Mouse Virulent Strain of Staphylococcus epidermidis," Jap. J. Microbiol., 20:209-217 (1976).
West et al., "Detection of Anti-teichoic Acid Immunoglobulin G Antibodies in Experimental Staphylococcus epidermidis Endocarditis," Infect. and Immun., 42:1020-1026 (1983).
Espersen et al., "Enzyme-linked Immunosorbent Assay for Detection of Staphylococcus epidermidis Antibody in Experimental S. epidermidis Endocarditis," J. Clin. Microbiol., 23:339-342 (1986).
Ichiman et al., "Relation of Human Serum Antibody Against Staphylococcus epidermidis Cell Surface Polysaccharide Detected by Enzyme-linked Immunosorbent Assay to Passive Protection in the Mouse," J. Appl. Bacteriol., 71:176-181 (1991).
Ichiman et al., "Monoclonal IgM Antibody Protection in Mice Against Infection with an Encapsulated Strain of Staphylococcus epidermidis," Can. J. Microbiol., 37:404-407 (1991).
Fischer et al., "Directed Immune Globulin Enhances Survival in an Intralipid Induced Neonatal Model of Lethal Staphylococcus epidermidis Sepsis," Pediatr. Res., Abstract No. 1670, p. 281A (Apr. 1991).
C.C. Patrick, "Coagulase-negative Staphylococci: Pathogens with Increasing Clinical Significance," J. of Pediatr., 116:497-507 (1990).
Freeman et al., "Association of Intravenous Lipid Emulsion and Coagulase-negative Staphylococcal Bacteremia in Neonatal Intensive Care Units," New. Engl. J. Med., 323:301-308 (1990).
J. O. Klein, "From Harmless Commensal to Invasive Pathogen: Coagulase-Negative Staphylococci," New Engl. J. Med., 323:339-340 (1990).
T. Niizuma, "Passive Protective Activities of Specific Human Immunoglobulin Against Strain ST67P of Staphylococcus hyicus Extracted from Pooled Human Sera," Chem. Abstracts, 115:181022v, p. 713 (1990).
T. Niizuma, "Passive Protection Activities of Specific Human Immunoglobulin Against Strain ST67P of Staphylococcus hyicus Extracted from Pooled Human Sera," St. Marianna Med. J., 18:940-946 (1990).
Certified English translation of document No. 10.
Espersen et al., "Solid Phase Radioimmunoassay IgG Antibodies to Staphylococcus epidermis: Use in Serious Coagulase-negative Staphylococcal Infections," Arch. Intern. Med., 147:689-693 (1987).

Affiliated with

Also associated with

Rating

Directed human immune globulin for the prevention and treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Directed human immune globulin for the prevention and treatment , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Directed human immune globulin for the prevention and treatment will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-77539